Fundraising September 15, 2024 – October 1, 2024 About fundraising

679. In vitro Activity of Cefiderocol (CFDC), a Novel...

679. In vitro Activity of Cefiderocol (CFDC), a Novel Siderophore Cephalosporin, Against Difficult-to-Treat-Resistant (DTR) Gram-Negative Bacterial Pathogens From the Multi-National Sentinel Surveillance Study, SIDERO-WT (2014–2017)

Longshaw, Christopher, Tsuji, Masakatsu, Hackel, Meredith M, Sahm, Daniel F, Yamano, Yoshinori
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz360.747
Date:
October, 2019
File:
PDF, 758 KB
2019
Conversion to is in progress
Conversion to is failed